US20110207766A1 - Lower dosage strength imiquimod formulations and short dosing regimens for treating genital and perianal warts - Google Patents

Lower dosage strength imiquimod formulations and short dosing regimens for treating genital and perianal warts Download PDF

Info

Publication number
US20110207766A1
US20110207766A1 US12/771,076 US77107610A US2011207766A1 US 20110207766 A1 US20110207766 A1 US 20110207766A1 US 77107610 A US77107610 A US 77107610A US 2011207766 A1 US2011207766 A1 US 2011207766A1
Authority
US
United States
Prior art keywords
imiquimod
subjects
treatment
study
placebo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/771,076
Inventor
Michael T. Nordsiek
Sharon F. Levy
James H. Lee
James H. Kulp
Kodumudi S. Balaji
Tze-Chiang Meng
Jason J. Wu
Valyn S. Bahm
Robert Babilon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medicis Pharmaceutical Corp
Original Assignee
Graceway Pharmaceuticals LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
Priority to US22520209P priority Critical
Priority to US34147610P priority
Priority to US34172110P priority
Application filed by Graceway Pharmaceuticals LLC filed Critical Graceway Pharmaceuticals LLC
Priority to US12/771,076 priority patent/US20110207766A1/en
Assigned to GRACEWAY PHARMACEUTICALS, LLC reassignment GRACEWAY PHARMACEUTICALS, LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BABILON, ROBERT, KULP, JAMES H., LEE, JAMES H., LEVY, SHARON F., NORDSIEK, MICHAEL T., WU, JASON J., BALAJI, KODUMUDI S., BAHM, VALYN S., MENG, TZE-CHIANG
Publication of US20110207766A1 publication Critical patent/US20110207766A1/en
Assigned to MEDICIS PHARMACEUTICAL CORPORATION reassignment MEDICIS PHARMACEUTICAL CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: GRACEWAY PHARMACEUTICALS, LLC
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43449661&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US20110207766(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application status is Abandoned legal-status Critical

Links